Northwest Biotherapeutics (NWBO) Revenue (2010 - 2026)
Northwest Biotherapeutics' Revenue came in at $807,000 for Q2 2026, up 516.0% from $131,000 a year earlier and up 63.4% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Revenue (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Northwest Biotherapeutics reported Revenue of $2.17 million, up 98.6% year-over-year; for FY2025, it came in at $1.38 million, down 0.3% from FY2024.
- Revenue carries a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- Going back by year, Revenue was $1.38 million in FY2024 (-28.5%), $1.93 million in FY2023 (+14.8%), $1.68 million in FY2022 (+67.5%) and $1.01 million in FY2021 (-22.2%).
- The Q2 2026 figure represents the highest quarterly Revenue since Q1 2023.
- Year-over-year, Revenue has increased for three consecutive quarters, with growth averaging 74.0% over the last eight quarters.
- The fastest year-over-year change in Revenue over five years came in Q2 2026 (growth of 516.0%), and the weakest in Q2 2025 (a decline of 74.3%).
- Business Quant data shows NWBO's Revenue at $494,000 (Q1 2026), $672,000 (Q4 2025) and $200,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - | 807,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 807,000.00 |
| Mar 31, 2026 | 494,000.00 |
| Dec 31, 2025 | 672,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 375,000.00 |
| Dec 31, 2024 | 231,000.00 |
| Sep 30, 2024 | 357,000.00 |
| Jun 30, 2024 | 510,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 445,000.00 |
| Sep 30, 2023 | 406,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 880,000.00 |
| Dec 31, 2022 | 597,000.00 |
| Sep 30, 2022 | 206,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | 403,000.00 |
| Sep 30, 2021 | 350,000.00 |
| Jun 30, 2021 | 416,000.00 |
API Access
Northwest Biotherapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();